ArticleIDCases2026
Rare bilateral optic neuritis following herpes zoster ophthalmicus in an immunocompetent adult: A case report.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Herpes zoster ophthalmicus is caused by reactivation of varicella-zoster virus in the ophthalmic division of the trigeminal nerve. Optic neuritis is an uncommon but vision-threatening complication, and bilateral optic nerve involvement in immunocompetent individuals is exceptionally rare. Case presentation: A 40-year-old immunocompetent man presented with acute right frontal and periorbital pain followed by a vesicular rash in the right ophthalmic division, including Hutchinson's sign. Initial visual acuity was normal, and oral valacyclovir was started. Within days, he developed rapidly progressive visual loss in the right eye with optic disc edema and right optic nerve enhancement on orbital magnetic resonance imaging. Cerebrospinal fluid analysis and systemic autoimmune and infectious workups were unrevealing. After admission, oral valacyclovir was switched to intravenous acyclovir, and oral corticosteroid therapy was initiated. On the following day, visual acuity in the right eye declined to light perception, and the previously unaffected left eye developed decreased visual acuity, impaired color vision, and visual field defects. Corticosteroid treatment was therefore escalated to intravenous methylprednisolone pulse therapy. Because of subsequent bilateral visual deterioration, intravenous immunoglobulin was added and administered for 5 days. Despite partial radiologic improvement, vision in the right eye progressed to permanent no light perception. Left eye visual acuity partially recovered to 0.9 (approximately 20/22 Snellen) at follow-up. Conclusion: This case highlights the fulminant course of herpes zoster ophthalmicus-associated optic neuritis and shows that bilateral optic nerve involvement may occur even in immunocompetent patients. Early recognition, close monitoring of both eyes, and prompt escalation of therapy are critical when optic nerve involvement is suspected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.